You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Article metrics

Article menu

Download PDFPDF

XML
Epidemiology/Health Services Research
Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

 

Online download statistics by month:

Online download statistics by month: March 2019 to July 2022

AbstractFullPdf
Mar 201923222874
Apr 201920018682
May 2019229223132
Jun 201920519880
Jul 201918818971
Aug 201917116966
Sep 201915315356
Oct 201913513566
Nov 2019828072
Dec 201913313152
Jan 202012311250
Feb 2020999923
Mar 2020999939
Apr 2020646420
May 2020626130
Jun 2020484824
Jul 2020595227
Aug 2020453434
Sep 2020937932
Oct 2020636234
Nov 2020685823
Dec 2020655731
Jan 2021464321
Feb 2021807431
Mar 2021504921
Apr 2021433912
May 2021313012
Jun 2021484613
Jul 2021797320
Aug 2021626019
Sep 2021959321
Oct 2021706740
Nov 2021272614
Dec 2021373913
Jan 2022222411
Feb 2022575214
Mar 2022414018
Apr 2022282514
May 2022484318
Jun 2022303016
Jul 2022312915
Total354133991461